|
15 Dec 2025 |
MphasiS
|
Consensus Share Price Target
|
2912.70 |
3058.34 |
- |
5.00 |
buy
|
|
|
|
|
25 Jul 2023
|
MphasiS
|
Bonanza
|
2912.70
|
2350.00
|
2268.10
(28.42%)
|
Target met |
Hold
|
|
|
Mphasis reported a miss in revenue, which fell 3.5% QoQ in cc terms, -3.4% QoQ / -8.4% YoY. The revenue decline was due to weakness in banking and capital markets (BCM, -8.8% QoQ, -14.8% YoY). BCM ex-mortgage was down 8.7% QoQ given delayed decision-making across large banks and weakness in regional banks.
|
|
23 Jul 2023
|
MphasiS
|
ICICI Securities Limited
|
2912.70
|
1727.00
|
2330.85
(24.96%)
|
|
Sell
|
|
|
Mphasis reported a miss in revenue, which fell -3.5% QoQ CC, -3.4% QoQ USD (I-Sec: -0.9%, cons: 0.01% USD) and -8.4% YoY CC. The revenue decline was due to weakness in banking and capital markets (BCM, -8.8% QoQ, -14.8% YoY). BCM ex-mortgage was down 8.7% QoQ given delayed decision-making across large banks and weakness in regional banks.
|
|
22 Jul 2023
|
MphasiS
|
BOB Capital Markets Ltd.
|
2912.70
|
2541.00
|
2330.85
(24.96%)
|
Target met |
Hold
|
|
|
Q1 missed estimates as dollar revenue slipped 3.4% QoQ following a slowdown in both direct business and DXC
|
|
29 May 2023
|
MphasiS
|
BOB Capital Markets Ltd.
|
2912.70
|
2541.00
|
1967.85
(48.01%)
|
Target met |
Buy
|
|
|
Weak Q4 revenue print (-4.1% QoQ); DR and DXC remained a drag on growth
|
|
02 May 2023
|
MphasiS
|
Bonanza
|
2912.70
|
2210.00
|
1861.05
(56.51%)
|
Target met |
Buy
|
|
|
Mphasis posted weak revenue print, yet maintained its margins. FY23 growth of 9.7% in cc terms was impacted by 4% from a decline in Digital Risk and 1.6% from a decline in DXC business. The increase in deal pipeline by 35% YoY including higher growth in non-BFSI deal pipeline is a sign of portfolio diversification and/or relative stress in BFSI (60% of revenue).
|
|
02 May 2023
|
MphasiS
|
ICICI Direct
|
2912.70
|
1950.00
|
1861.05
(56.51%)
|
Target met |
Hold
|
|
|
|
|
29 Apr 2023
|
MphasiS
|
ICICI Securities Limited
|
2912.70
|
1812.00
|
1814.45
(60.53%)
|
Target met |
Hold
|
|
|
Mphasis has reported a revenue decline of -4.5% QoQ CC and -4.1% QoQ US$, much lower than our and consensus estimates (vs ISEC: -0.5% QoQ US$, BBG cons: -0.3% QoQ US$) in Q4FY23. Direct revenue growth declined 3.4% QoQ CC and DXC declined 24.8% QoQ CC.
|
|
29 Mar 2023
|
MphasiS
|
Hem Securities
|
2912.70
|
2032.00
|
1718.20
(69.52%)
|
Target met |
Buy
|
|
|
|
|
23 Jan 2023
|
MphasiS
|
ICICI Direct
|
2912.70
|
2070.00
|
2058.80
(41.48%)
|
Target met |
Hold
|
|
|
|
|
23 Jan 2023
|
MphasiS
|
Bonanza
|
2912.70
|
2420.00
|
2024.65
(43.86%)
|
Target met |
Buy
|
|
|
We find Mphasis much better placed compared to peers with a handle on its operating parameters and a risk reward that is tilted favourably (since MPHL is available at relatively cheaper valuations compared to peers).cheaper valuations compared to peers).
|